Navigation Links
CORRECTED: Bionovo Announces Second Quarter 2011 Highlights and Financial Results
Date:8/5/2011

EMERYVILLE, Calif., Aug. 5, 2011 /PRNewswire/ -- CORRECTED -- Bionovo, Inc. (NASDAQ: BNVI) today announced second quarter highlights and financial results for the three months ended June 30, 2011.

"We have made excellent progress on our menopausal hot flash drug candidate, MF101, or Menerba™, during the past quarter, delivering on milestones and commitments," said Isaac Cohen, O.M.D., Bionovo's Chairman and Chief Executive Officer. "We have completed the tasks which were required for us to begin the phase 3 clinical trial for Menerba, and we are on track to initiate the trial in the third quarter."

Key Events and Milestones

  • The Company successfully completed non-clinical toxicology studies of Menerba in two animal species.  As expected no serious adverse events or toxicities were observed in these studies. The drug was well tolerated by the animals.
  • The Company successfully completed a 28-day tolerability trial of Menerba in women, investigating higher doses. As expected, there were no safety concerns, no reports of serious adverse events, no changes to blood pressure, heart rate or lab values and no cases of abnormal uterine findings on endometrial biopsies.  A dosing strategy has been established for the phase 3 study.
  • The Company completed the manufacture of the requisite ten batches for the phase 3 clinical trial of Menerba, and is preparing the submission of data to the FDA.
  • The Company has identified, selected, and is working with personnel at 45 initial clinical trial sites for the phase 3 clinical trial of Menerba.
  • The Company also published further information on the mechanism of action of its breast cancer drug candidate, Bezielle™, as well as further information on novel approaches for the quantification of actives in botanical drug mixtures.
  • The Company presented data from
    '/>"/>

  • SOURCE Bionovo, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5

    Related medicine technology :

    1. Bionovo Announces Positive Developments in On-going Phase 1/2 Cancer Drug Trial
    2. Bionovo Announces Publication of the Paper Detailing the Mechanism of Action of Its Cancer Drug BZL101
    3. Bionovo Discovers New Estrogen Regulatory Elements for Breast Cancer and Osteoporosis Drugs
    4. Bionovos Drug Candidate for Menopausal Symptoms Shows Effect on Neural Pathways Related to Temperature Regulation
    5. Bionovo Elucidates Mechanism of Breast Cancer Control by Estrogen Receptor Beta
    6. Bionovo Reports on Metabolic Studies Related to Its Menopausal Hot Flash Drug Candidate
    7. Bionovos MF101 Shows Statistically Significant Improvement in Sleep Disturbance from Hot Flashes
    8. Bionovos VG101 Shows Greater Efficacy Than Estrogen in the Treatment of Vaginal Dryness
    9. Bionovo Advances BZL101 to Phase 2 Clinical Trials After Positive Phase 1 Results for Metastatic Breast Cancer
    10. Bionovo Presents Positive Results from Phase 1B Trial of BZL101 for Metastatic Breast Cancer at the Society for Integrative Oncology
    11. Bionovo Announces Development Plans for Menopausal Hot Flash Drug Candidate, Menerba (MF101), Following FDA Meetings
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:2/27/2015)...   Synageva BioPharma Corp. (Synageva) (NASDAQ: ... therapeutic products for rare diseases, joins the National ... for Rare Diseases™ (EURORDIS™), The Global Genes Project™, ... Disease Day. On the last day ... other participants conduct special events to raise awareness ...
    (Date:2/27/2015)... Israel , February 27, 2015 /PRNewswire/ ... baut sein bahnbrechendes Überwachungssystem für kongestive Herzinsuffizienz ... aus -     ... Technologies, die ein neuartiges Herzüberwachungssystem für Patienten ... heute bekannt, dass sie ein Finanzierungsvorhaben über ...
    (Date:2/26/2015)... Feb. 27, 2015  Finesse expands office in ... announced the expansion of its operations in ... mid-March and access for customers is expected shortly afterward. ... located adjacent to the current office, the new premises ... team and allow Finesse to bring on more service ...
    Breaking Medicine Technology:Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 2Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 3Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 4Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 5Synageva BioPharma Joins NORD, EURORDIS, And The Global Genes Project In Support Of Rare Disease Day 2015 6Vectorious Medical Technologies schließt Finanzierungsvorhaben über 5 Mio. USD ab 2New Finesse Office in United Kingdom 2
    ... Omeros Corporation (Nasdaq: OMER ... that interact with three orphan G protein-coupled receptors (GPCRs) ... breakthrough demonstrates Omeros, unique capability to introduce a large ... which could lead to the development of novel therapeutics ...
    ... , June 29 Reportlinker.com announces that a new market research report is available in ... Disease and Therapy Review: Bladder Cancer , ... http://www.reportlinker.com/p0210878/Disease-and-Therapy-Review-Bladder-Cancer.html , , , ... , The Bladder Cancer Disease and Therapy ...
    Cached Medicine Technology:Omeros Successfully Unlocks Orphan GPCRs 2Omeros Successfully Unlocks Orphan GPCRs 3Omeros Successfully Unlocks Orphan GPCRs 4Reportlinker Adds Disease and Therapy Review: Bladder Cancer 2Reportlinker Adds Disease and Therapy Review: Bladder Cancer 3Reportlinker Adds Disease and Therapy Review: Bladder Cancer 4
    (Date:2/28/2015)... Bethesda, MD (PRWEB) February 28, 2015 ... annual conference in person, the Mesothelioma Applied Research ... taking place on Tuesday, March 3, starting at 9:30 ... and requires no registration. The broadcast can be accessed ... visiting http://www.curemeso.org/symposium . , The Symposium is a ...
    (Date:2/28/2015)... February 28, 2015 Pioneer Millworks reclaimed ... Japan Architecture & Construction Materials Show, an annual, premier ... than 1,000 suppliers and top manufacturers of the latest ... wood products sourced and manufactured by Pioneer Millworks ... popularity in Japan at restaurants, hotels, retailers, and corporate ...
    (Date:2/28/2015)... 2015 Dr. Perry Patel , ... residents, recently announced a special offer for the Zoom!® ... option for new and established patients at his Pismo Beach ... bright, white smile, Dr. Patel and his staff are ... down from the regular price of $450. , Zoom! ...
    (Date:2/28/2015)... NY (PRWEB) February 28, 2015 A ... federal testosterone lawsuits that have been filed by law ... the second week in March, the Firm notes. ... website, parties involved in the federal litigation will meet ... matters related to prescription therapy treatments designed to raise ...
    (Date:2/28/2015)... (PRWEB) February 28, 2015 How ... Supportive? Strategic? , There are all kinds of ... To raise awareness of the advantages and applications ... PeopleKeys is launching a new product this spring ... better understand the connection between personality type, leadership, ...
    Breaking Medicine News(10 mins):Health News:Mesothelioma Cancer Research Foundation Broadcasting Symposium Live 2Health News:US Reclaimed Wood from Pioneer Millworks to be Featured at Architecture & Construction Materials Show in Tokyo. 2Health News:Pismo Beach Dentist Announces Special for Zoom! Teeth Whitening 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 2Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 3Health News:Bernstein Liebhard LLP Notes Approaching Conference in Federal Litigation that Includes Numerous Testosterone Lawsuits Filed by the Firm 4Health News:PeopleKeys Launches The Leadership Report 2Health News:PeopleKeys Launches The Leadership Report 3
    ... researchers from the University of Valencia (UV) has proven that ... to what is published in the journal Photochemistry and ... from the Sun, but not the diffused radiation that penetrates ... irradiance (radiation incidence per unit of surface area) that reaches ...
    ... Mothers who drank milk with a probiotic supplement during and ... in their children by almost half, a new study published ... The randomized, double-blind study, conducted by researchers at the ... drank one glass of probiotic milk a day to women ...
    ... AUSTRIA, 20 July 2010 Results from the ... 2010), a multi-country survey of more than 2,000 ... gap in patient-physician dialogue about critical health-related conditions ... quality of life, and treatment outcomes. The ...
    ... MONDAY, July 19 (HealthDay News) -- Regular cell phone use ... ear -- a condition known as tinnitus, a small Austrian ... data used for the study "very weak," adding that the ... and tinnitus. The study,s lead researcher, Dr. Hans-Peter Hutter ...
    ... , MONDAY, July 19 (HealthDay News) -- An analysis ... children might detect differences in vocalization and help researchers ... delays, a new study suggests. "This automated application ... objective way," said lead researcher Dr. D. Kimbrough Oller, ...
    ... By Randy Dotinga HealthDay Reporter , MONDAY, July 19 ... levels of the chemicals known as PCBs in their bodies were ... found, but it,s not clear if the PCBs actually caused their ... indicate a serious health threat to those exposed to PCBs, which ...
    Cached Medicine News:Health News:Beach umbrellas do not block out all solar radiation 2Health News:Probiotics use in mothers limits eczema in their babies 2Health News:Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations 2Health News:Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations 3Health News:Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations 4Health News:Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations 5Health News:Global HIV/AIDS survey by IAPAC reveals critical gap in patient-physician conversations 6Health News:Can Cell Phones Cause Another Kind of Ringing? 2Health News:Voice Recorders Seem to Help Detect Autism 2Health News:Could PCBs Help Boost Blood Pressure? 2Health News:Could PCBs Help Boost Blood Pressure? 3
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size....
    Each handle is designed to fit a specific trephine size. For use in performing free-hand uniform donor buttons....
    Medicine Products: